Stuart Poulton - EVP, Chief Development Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Development Officer
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Stuart Poulton - trading volume in the past year for Karyopharm Therapeutics Inc.

Holdings reported by Stuart Poulton for Karyopharm Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common 330K $395K $1.20 Mar 1, 2024 Direct
Common Stock 327K $346K $1.06 Jul 30, 2024 Direct

Transactions reported by Stuart Poulton for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.